{
  "ptid_time": "031_S_4042_2013-02-21",
  "img_path": "/data/qiuhui/data/adni/images/031_S_4042/2013-02-21/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 14,251 mm³, 43.0% below the reference mean. With a Z-score of -0.57 (28.4th percentile), this represents normal volume ; hippocampal volume measures 8,068 mm³.; whole brain volume measures 985,693 mm³, 17.3% below the reference mean. With a Z-score of -3.20 (0.1th percentile), this represents profound atrophy; entorhinal cortex volume measures 4,786 mm³, 19.6% above the reference mean. With a Z-score of 1.72 (95.7th percentile), this represents moderate enlargement; fusiform gyrus volume measures 15,465 mm³, 25.8% below the reference mean. With a Z-score of -3.92 (0.0th percentile), this represents profound atrophy; middle temporal gyrus volume measures 18,079 mm³.. ",
  "text_data": "Age is 59.2 years. Gender is Male. Education: 18 years. MMSE: 26.0. MoCA: 20.0. Logical Memory: 4.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.38 SUVR (significant elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "Reasoning: The data shows profound atrophy in whole brain volume (Z-score -3.20) and fusiform gyrus (Z-score -3.92), along with significant amyloid burden (AV45+). Despite normal hippocampal volume, the MoCA score of 20 indicates cognitive impairment, while the MMSE of 26 is borderline. The absence of APOE4 does not rule out dementia given the structural and biomarker findings.  \n\nDiagnosis: Dementia (likely Alzheimer’s disease given amyloid positivity and temporal lobe atrophy)  \nConfidence: High",
  "timestamp": "2025-07-26T04:46:40.340288"
}